ResearcherUniversity of MichiganNo recent work listed
Jeffrey M. Vainshtein
Matched on OpenAlex author ID A5111889160. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper
Papers 2
- Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. Co-author DOI 10.1097/coc.0000000000000200↗
- Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiati… Co-author DOI 10.1016/j.ijrobp.2012.11.020↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Theodore Steven Lawrence · 2 shared papers, 2013–2017 · strength 0.10
- Paper Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Rad… DOI 10.1097/coc.0000000000000200↗
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Mark M. Zalupski · 2 shared papers, 2013–2017 · strength 0.10
- Paper Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Rad… DOI 10.1097/coc.0000000000000200↗
- Paper Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with do… DOI 10.1016/j.ijrobp.2012.11.020↗
- Mary Uan-Sian Feng · 1 shared paper, 2017 · strength 0.06
- Jessica Q. Zhou · 1 shared paper, 2017 · strength 0.06
- Diane M. Simeone · 1 shared paper, 2017 · strength 0.06
- William Leslie · 1 shared paper, 2013 · strength 0.04
- Ross Allen Abrams · 1 shared paper, 2013 · strength 0.04
- Edgar Ben‐Josef · 1 shared paper, 2013 · strength 0.04
- Isaac R. Francis · 1 shared paper, 2013 · strength 0.04
- Gazala Naaz Khan · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.